| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-12 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-09 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |